In light of the increasing number of post-translational mechanisms regulating IGF2 expression and biological function, especially in cancer, we believe that focusing the current review on the control of IGF2 at the gene transcription and RNA transcript levels and separating clearly from the post-translational mechanisms is far more important. The gene discussed is IGF2; the disease is cancer.